n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, February 2nd, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Kiwa Bio-Tech Products Group Corporation (KWBT)

Wallstreetlivechat, Lions of Wall Street, Fast Moving Stocks, Darth Trader, The Stock Psycho, Top Gun, Penny Stock Rumble, StockMister, The Penny Play, Equities.com, SmallCapVoice, and OTC Picks reported previously on Kiwa Bio-Tech Products Group Corporation (KWBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kiwa Bio-Tech Products Group Corporation is a manufacturer focusing on eco-friendly bio-based fertilizers promoting soil health. The Company develops, manufactures, distributes, and markets novel, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. Kiwa Bio-Tech Products Group has its head office in Claremont, California.

The design of Kiwa’s products are to enhance the quality of human life through increasing the value, quality, and productivity of crops and lessening the negative environmental impact of chemicals and other wastes. The Company uses new bio-technological skills at its core. Organic, ecologically sound, and "green" practices are its theme.

Kiwa’s dedication is to eco-agricultural development and environmental control through developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy increasing market demand. The Company’s commitment is to making safe food, further developing eco-agriculture, and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle.

Kiwa Bio-Tech has a strategic cooperation agreement with the Beijing Zhongpin Agricultural Science and Technology Development Center (Zhongpin Center). Zhongpin Center is the Chinese Agricultural Science and Technology Innovation and Development Committee's executive implementation agency (named the Agricultural Science and Technology Commission).

Via the guidance and support by the Zhongpin Center, Kiwa Bio-Tech will participate and be involved in China's National Soil Remediation Program and building of the National Ecological Security Agriculture Industrial Chain Standardization System's operation and process.

Kiwa Bio-Tech launched a joint venture (JV) with Zhongshi'an Agricultural Science & Technology Co., Ltd. and Xintaitianyi Financial Service and Science & Technology Co., Ltd. The name of the JV is Inner Mongolia Jingnong Investment Management Co. Ltd.

Kiwa Bio-Tech is a 40 percent partner in the venture. Jingnong will invest in the expansion of Kiwa Bio-Tech’s existing production base in Shandong Province and in the building of three new manufacturing bases of Kiwa in Inner Mongolia Province, Xinjiang Province, and Guizhou Province.

Kiwa’s new products structure includes 16 types of products in 5 major categories. These categories are Biological Organic Fertilizer, Compound Microorganism Fertilizer, Microorganism Bacterium Agent, Biological Soluble Fertilizer, and Organic-Inorganic Compound Fertilizer.

In January, Kiwa Bio-Tech announced that it signed a strategic cooperative agreement with the administration committee of Yangling Area of China (Shaanxi) Pilot Free Trade Zone (Yangling). Kiwa Bio-Tech will form a subsidiary company in Yangling to further develop its harmless agriculture business. The two parties will create a Research Institute of Kiwa Bio-Tech Agricultural Biological Technology.

They will also establish a Kiwa Bio-Tech Fermentation Factory for fertilizer products, as well as a Comprehensive Trading and Logistics Center for International Agricultural Materials, Agricultural Products, Agricultural Machinery and Traditional Chinese Medicine (TCM). They will also create an Agriculture Standard System.

Moreover, in January, Kiwa Bio-Tech announced that it established two retail outlet stores in Hu County, Zhouzhi County in Shaanxi Province, respectively. The establishment of the outlet stores supports the Company’s business strategy regarding planting harmless crops, selling organic fertilizer products, and agricultural products buy-back.

Today, Kiwa Bio-Tech announced that it signed a Strategic Cooperation Agreement with The People's Insurance Company (Group) of China Limited (PICC). This agreement was signed with The People's Insurance Company (Group) of China Limited Xi’an Branch. It is centered on providing agricultural insurance and financing for Kiwa Bio-Tech’s clients.

Kiwa Bio-Tech Products Group Corporation (KWBT), closed Friday's trading session at $2.00, up 14.29%, on 6,100 volume with 7 trades. The average volume for the last 60 days is 2,085 and the stock's 52-week low/high is $1.01/$3.57.

Mikros Systems Corp. (MKRS)

OTCEquity, PennyStocks24, AwesomeStocks, Wall Street Mover, PricelessPennyStocks, Promotion Stock Secrets, Marketbeat.com, Fast Money Alerts, Actual Gains, AddictivePennyStocks, Chatter Box Stocks, StockLockandLoad, PennyStockRumors.net, StockRockandRoll, StockBomb, ResearchOTC, and OTPicks reported on Mikros Systems Corp. (MKRS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise that designs and manufactures specialized electronic systems for the Department of Defense. Its chief business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. The Company is headquartered in Princeton, New Jersey, and has its Manufacturing and Depot Center in Largo, Florida.

Mikros produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.

The Company has developed, delivered, and installed military-grade equipment to Federal customers’ for more than 30 years. Its capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering.

Mikros Systems’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to accomplish the highest levels of system readiness. The Company purchased certain software products, intellectual property (IP) and related assets from VSE Corp. The main software programs purchased by Mikros are the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs.

The Diagnostic Profiler software is used globally by many multinational companies for optimized maintenance of varied product lines. Diagnostic Profiler is also used by the U.S. Air Force for depot test programs.

Prognostics Framework is used by the U.S. Army for many missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.

In September 2017, Mikros Systems announced that it received the second production order awarded under its recent multi-year $35M contract with the Naval Surface Warfare Center in Crane, IN. This order covers new production deliveries of Mikros' Adaptive Diagnostic Electronic Portable Testset (ADEPT). It is valued at $2.4 million. The ADEPT units will be produced at the Mikros Manufacturing and Depot Center in Largo, FL.

Mikros has successfully completed the first ship and shore installation and testing of its ADEPT Distance Support Sensor Suite (ADSSS) on the Littoral Combat Ship USS INDEPENDENCE (LCS 2). As installed on LCS 2, ADSSS will utilize the Company’s proprietary model-based Prognostics Framework technology to monitor combat system elements to detect and predict on-ship system failures and apply predictive analytics to on-shore systems to detect broader maintenance trends and patterns across the fleet.

ADSSS Program Manager, Lori Ogles, said earlier in December, "Mikros has been a proud partner of the U.S. Navy for over fifteen years. We are honored to continue to support the readiness of U.S. Navy combat systems with our condition-based maintenance solution and we look forward to expanding the ADSSS technology to additional LCS and U.S. Naval platforms."

Mikros Systems Corp. (MKRS), closed Friday's trading session at $0.456325, up 1.41%, on 4,250 volume with 2 trades. The average volume for the last 60 days is 18,224 and the stock's 52-week low/high is $0.24/$0.63.

Amerityre Corp. (AMTY)

Marketbeat, Real Pennies, CoolPennyStocks, TopPennyStockMovers, Money Morning, and Stock Rich reported on Amerityre Corp. (AMTY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Amerityre Corp. engages in the research and development (R&D), manufacture, and sale of polyurethane tires. The Company initially developed polyurethane foam tires based on proprietary chemical formulations. It has invented new polyurethane foam and elastomer materials that it believes are superior to rubber in several tire applications.

Amerityre concentrates on three segments of the tire market - closed-cell polyurethane foam tires, polyurethane elastomer forklift tires, and agricultural tires. All of its tires are manufactured in the United States. Amerityre is headquartered in Boulder City, Nevada and the Company lists on the OTC Markets’ OTCQB.

Amerityre has in-house product formulation development and tire design capabilities. The Company can design and manufacture custom tires to address exact client applications.

Amerityre’s advanced polyurethane materials are environmentally friendly. Also, they can be recycled. Regarding agricultural tires, the Company has developed two products for this market, one used in irrigation and one used in planting. Both products have successfully field tested.

The Company has developed a high density, closed cell foam material – using proprietary polyurethane chemical formulations, which it believes are superior in low speed foam tire applications. Amerityre’s materials are UV and ozone resistant and long-lasting. Its foam tires can never go flat; as such, the Company calls them Flatfree.

Its tires consist of high density foam. They exhibit low rolling resistance. The polyurethane foam tires do not absorb water and suffer performance degradation in wet environments.

The underpinning of Amerityre’s polyurethane material technology is on proprietary formulations. One is closed-cell polyurethane foam. This is a lightweight material with high load-bearing capabilities for low duty cycle applications.

The other is Polyurethane Elastomer Technology - Kryon™ and Elastothane™. Amerityre has created many polyurethane elastomer chemical formulations having superior temperature, abrasion, and elastic properties. These materials are used in forklift tires and agricultural tire applications.

Amerityre reported its first annual profit in Fiscal Year (FY) 2017. Increased Gross Margins from 29.4 percent to 32.6 percent were the driver of the higher profitability. The Company’s Sales Revenue, year-over-year, decreased by 4 percent. Increased sales of larger closed cell foam tires offset unsatisfactory sales in agricultural and industrial tire market segments.

Amerityre’s FY 2018 goal is manufacturing flexibility and capacity optimization. The Company states that the product pricing model is a prominent tool for making business decisions. Its objectives include identifying and developing relationships with new distribution partners to grow overall Sales Revenue by 10 percent. Its objectives also include continuing development of new formulations and new products to address market needs.

Amerityre Corp. (AMTY), closed Friday's trading session at $0.0185, down 7.50%, on 19,600 volume with 4 trades. The average volume for the last 60 days is 48,023 and the stock's 52-week low/high is $0.0124/$0.043.

hopTo, Inc. (HPTO)

Tiny Gems, Money Morning, Marketbeat, Wall Street Mover, SmallCapVoice, TopPennyStockMovers, and PennyStocks24 reported earlier on hopTo, Inc. (HPTO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

hopTo, Inc. is a developer of application publishing software and a mobile productivity workspace platform. The hopTo mobile solution delivers a first-rate user experience without compromising enterprise security. It delivers a mobile experience that changes the way one works and lives without any compromises or boundaries. The Company is a Citrix Ready® Premier Partner. hopTo is headquartered in Concord, New Hampshire.

The hopTo mobile solution enables one to completely embrace a mobile lifestyle. hopTo brings a new standard of mobile productivity with custom, touch enabled access to existing Windows applications and documents. hopTo are developers of application software. This includes application virtualization software and cloud computing software for multiple computer operating systems. This includes Windows, UNIX, and a number of Linux-based variants.

hopTo Work enables customers to rapidly transform their legacy applications to become touch friendly on modern mobile devices. Moreover, hopTo worked during 2015 and 2016 to integrate hopTo Work with certain software products offered by Citrix Systems.

The Company’s application publishing software solutions sell under the brand name GO-Global. GO-Global is an application access solution for use and/or resale by independent software vendors (ISVs), corporate enterprises, governmental and educational institutions, and others who desire to leverage cross-platform remote access and Web-enabled access to their existing software applications, as well as those who are installing secure, private cloud environments.

This past November, hopTo announced its financial results for Q3 ended September 30, 2017. For Q3 2017, Revenue was $1.026 million; Net Profit was $254,000; and Basic and Diluted Earnings per Share was $0.03.

Total Revenue for the first nine months of Fiscal Year 2017 was $2.93 million. This represents an increase of about 2.4 percent from $2.86 million for the same period in 2016. This revenue is entirely from hopTo’s GO-Global products and services.

For the first nine months of 2017, hopTo reported a Net Profit of $87,000 or $0.01 per basic and diluted share. This is in comparison with a Net Loss of $1.87 million or $0.19 per basic and diluted share from the same period last year.

Jean-Louis Casabonne, hopTo’s interim Chief Executive Officer, said, "The GO-Global business continues to generate positive cash flow and remains a critical aspect of the company. The GO-Global business has now shown modest growth year over year for both the three and nine month periods ended September 30, 2017 strengthening our belief that it will operate profitably in the future. Early in the third quarter, we completed a sale of seven of our fifty-three granted patents which has further improved the cash position of the Company. This sale included a license back to hopTo for those patents."

hopTo, Inc. (HPTO), closed Friday's trading session at $0.2075, up 9.21%, on 648 volume with 5 trades. The average volume for the last 60 days is 15,775 and the stock's 52-week low/high is $0.016/$0.35.

Star Navigation Systems Group Ltd. (SNAVF)

StreetInsider, MarketWatch, Stockhouse, Marketwired, OTC Markets, Business Insider, Equities, and PennyStockHub reported on Star Navigation Systems Group Ltd. (SNAVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Star Navigation Systems Group Ltd. owns the exclusive global license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®. This is the core of the STAR-A.D.S. ® System. The Company’s M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defense and commercial aviation industries around the world. Listed on the OTC Markets Group’s OTCQB, Star Navigation Systems has its corporate office in Toronto, Ontario.

The Company provides hardware and software platforms. This includes the STAR-A.D.S.™, which is real-time global tracking and monitoring systems. In addition, platforms include the STAR-MMI™, which is flat panel and LCD displays and control units.

STAR-MMI™ has developed an extensive range of AMLCD flat panel display sizes, with LED Backlights, resolutions, as well as orientations. These displays are found on aircraft and simulators, from P-3 Orion and C-130 aircraft, to Sikorsky and AgustaWestland helicopters, among others.

Star Navigation Systems developed the above-mentioned STAR-ISMS® In-flight Safety Monitoring System. This is the first system in the world to feature in-flight data monitoring and diagnostics with a real-time, secure connection between aircraft and ground.

STAR-ISMS® continuously monitors selected avionics systems on the aircraft from power-on to power-off. It immediately analyzes the data, and transmits selected data and any incident alerts, by way of satellite to the operator.

The Company also offers STAT-T.T.T. This is a satellite flight tracking and voice/text communications system. Furthermore, it offers STAR-ISMS-Medevac. This is a real-time telemedicine for emergency medical evacuation via air transportation.

In early January 2018, Star Navigation Systems Group announced its first orders of the year for its’ STAR Man Machine Interface Division (STAR- M.M.I. ™). STAR- M.M.I. ™ received a new set of repair orders from Lockheed Martin under the recently implemented agreement for refurbishment and maintenance. The agreement covers activities up to the year 2021.

Star Navigation Systems Group Ltd. (SNAVF), closed Friday's trading session at $0.0671, up 37.78%, on 318,000 volume with 6 trades. The average volume for the last 60 days is 10,318 and the stock's 52-week low/high is $0.0139/$0.185.

SCI Engineered Materials, Inc. (SCIA)

InvestorsHub and OTC Markets reported on SCI Engineered Materials, Inc. (SCIA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

SCI Engineered Materials, Inc. is a global supplier and manufacturer of advanced materials for physical vapor deposition (PVD) thin film applications. This includes thin film solar products. The Company works closely with end users and original equipment manufacturers (OEMs) to develop unique, customized solutions. It provides targeted solutions for thin film applications. OTCQB-listed, SCI Engineered Materials is based in Columbus, Ohio.

The Company is an ISO 9001-2015 Registered Provider of PVD Materials. It is a “Full Service Materials Provider” for PVD applications. SCI is a recognized leader in the development of “Transparent Conductive Oxide (TCO)” materials for varied industries. SCI continues development with Universities and Research Institutes internationally.

SCI provides ceramic and metal targets for use in sputtering and laser ablation systems. Furthermore, the Company manufactures high performance metal, ceramic, and alloy bulk-form evaporation sources in almost any customer defined configuration.

In addition, SCI processes a wide assortment of custom ceramic powders in house. It offers a broad variety of single crystal substrates for making first-class thin films. Services that SCI provides include advanced ceramic powers, vacuum hot pressing, machining, bonding, and quality assurance.

The major markets that SCI Engineered Materials serves include architectural glass, optic & photonic, solar photovoltaic, transparent electronics, and solid state lithium thin film battery. The Company provides precision machining of backing plates & tubes to customer or OEM specifications.

SCI Engineered Materials announced in June of last year that it entered into a joint project with Case Western Reserve in their Summer Undergraduate Research in Energy and Sustainability program. The objective of the project is to measure the band gaps and work function of several materials now undergoing development by SCI through in-house research and development (R&D) activities.

Case Western Reserve was to evaluate test films to determine if SCI's materials have superior properties to replace Cadmium Sulfide and/or intrinsic Zinc Oxide in Copper Indium Gallium Selenide (CIGS) thin film solar products.

Subsequent, SCI Engineered Materials announced Case Western Reserve University’s (CWRU) successful evaluation of test films utilizing SCI’s Zinc Magnesium Oxide (MZO) material. The results support use of SCI’s innovative material in thin film solar applications that could lead to higher efficiencies.

Yesterday, SCI Engineered Materials reported its financial results for the twelve months and three months ended December 31, 2017.

Mr. Dan Rooney, the Company’s President & Chief Executive Officer, said, “The positive 2017 results can be attributed to changes in the strategy we implemented during in the second half of 2016. These achievements included a 24 percent increase in revenue, a 45 percent increase in gross profit and a 12 percent decrease in operating expenses compared to 2016; resulting in net income of $6,091 compared to a net loss of $(706,054) in 2016. EBITDA for the year 2017 was more than $519,000, the highest annual amount since 2010.”

SCI Engineered Materials, Inc. (SCIA), closed Friday's trading session at $0.95, up 5.56%, on 3,400 volume with 4 trades. The average volume for the last 60 days is 3,390 and the stock's 52-week low/high is $0.53/$1.56.

Medovex Corporation (MDVX)

StockTwits reported on Medovex Corporation (MDVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medovex Corporation is the developer of the DenerveX® System. This is a new and novel device designed for enduring relief of Facet Joint Syndrome (FJS) related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle. The Company established to acquire and develop a diversified portfolio of potentially pioneering medical technology products. OTCQB-listed, Medovex is based in Atlanta, Georgia.

Facet Joint Syndrome (FJS) is also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis. FJS is a significant health and economic problem in the U.S. and other countries in the EU and Rest of World affecting millions annually. Present treatment options are generally temporary. There is no proven long-lasting option for FJS.

The healthcare executives at Medovex have a proven record of accomplishment of building successful medical device and biotechnology companies. The Company’s DenerveX System is CE Marked in Europe. In addition, it is commercially available in Europe and certain other worldwide markets.

The DenerveX System is a highly differentiated technology. It denervates and removes capsular tissue from the Facet Joint in one single procedure. Treatment results from the combined effect of a deburring or polishing action and RF ablation treatment on the Facet Joint.

Employing this new technique, the slowly rotating burr removes the targeted facet joint synovial membrane and joint surface. This is while the heat ablation destroys tissue and denudes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue of the joint.

In November, Medovex announced that it submitted an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA) for its DenerveX System targeting pain associated with the Facet Joint. The submission of the IDE marks a significant milestone for the Company.

This past September, Medovex announced that it launched its DenerveX System Device in Spain with leading distributor Prim SA. In October, Medovex announced that it launched its DenerveX System Device in Switzerland with distributor Spine Surgical. Switzerland is one of the most important locations for the worldwide medical technology industry.

Through combining first-class research facilities and highly-developed healthcare systems, Switzerland presents itself as a very attractive location for research, development and production for the medical technology sector.

The DenerveX System consists of the DenerveX Kit, which contains the DenerveX Device, a single use medical device and the DenerveX Pro-40 Power Generator. The DenerveX system is not yet FDA cleared.

Medovex Corporation (MDVX), closed Friday's trading session at $0.5099, up 7.35%, on 14,545 volume with 8 trades. The average volume for the last 60 days is 59,601 and the stock's 52-week low/high is $0.415/$1.68.

Black Cactus Global, Inc. (BLGI)

Stockopedia, InvestorsHub, OTC Markets, Insider Financial, 4-Traders, Morningstar, Stockhouse, Simply Wall St, MarketNewsUpdates, TipRanks, InvestorsHangout, Dividend Investor, PennyStockHub, StreetInsider, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, and The Street reported on Black Cactus Global, Inc. (BLGI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development company listed on the OTC Markets Group’s OTCQB. The Company centers on Blockchain, machine learning, cryptocurrency, as well as the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. Black Cactus Global is headquartered in Las Vegas, Nevada.

Black Cactus Global’s strategic plan is to become the first fully integrated digital financial institution with Blockchain technology as its operating foundation. The Company is developing Blockchain applications for Fintech, Healthcare, Media and Supply Chain using smart contracts and machine learning.

Black Cactus’ services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems. Its services additionally include Crypto Currencies, Internet of Things (IoT), Smart Contracts, and Fintech & Medtech.

Last month, Black Cactus Global announced that it entered into a Memorandum of Understanding (MOU) with NSB Holdings ehf (NSB) of Iceland. The details of the MOU map out the plan for Black Cactus to become the majority stakeholder of a bank in Iceland to create the first completely digital bank. Black Cactus Global, in cooperation with NSB, will convert and quickly develop the world’s first full-service Digital Bank founded on Blockchain Technology.

In addition, in January, Black Cactus Global announced that it entered into an MOU with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With this MOU, Black Cactus will become the largest stakeholder of an international Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will concentrate on and advance the use of its inventive Blockchain based IP.

Today, Black Cactus Global announced that Dr. Ramesh Para was appointed to the Board of Directors. Dr. Para holds a Ph.D. in Management Information Systems and also an MBA. He is Director of Sysveda UK Limited, which is an information sciences consultancy where he has led projects in Systems Development, Technical Architecture, Data Engineering and Distributed Applications.

Black Cactus Global, Inc. (BLGI), closed Friday's trading session at $0.346, even for the day, on 647,599 volume with 277 trades. The average volume for the last 60 days is 288,917 and the stock's 52-week low/high is $0.03/$0.838.

Ocean Thermal Energy Corporation (CPWR)

OTC Markets, InvestorsHub, MarketWatch, YCharts, 4-Trders, Barchart, Investopedia, Marketbeat, Tidal Energy Today, Insider Monkey, Stockhouse, and Simply Wall St reported on Ocean Thermal Energy Corporation (CPWR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ocean Thermal Energy Corporation constructs and operates clean hydrothermal energy plants around the world. The Company is a project developer for Ocean Thermal Energy Conversion (OTEC) plants that create renewable energy. It designs and develops deep-water hydrothermal clean-energy systems that produce fossil-fuel free electricity through OTEC and environmentally friendly cooling through Seawater Air Conditioning (SWAC).

Ocean Thermal Energy is headquartered in Lancaster, Pennsylvania. The Company has additional offices in the Bahamas, the Cayman Islands, and the U.S. Virgin Islands. Established in 1998, Ocean Thermal Energy lists on the OTC Markets’ OTCQB.

OTEC takes advantage of the temperature difference in the ocean between cold deep water and warm surface water in the tropics and subtropics to produce unlimited energy without the use of fossil fuels. In a closed cycle OTEC system, water flows through a large pipe and heat exchanger that heats a liquid with a low boiling point, such as ammonia.

As the boiling ammonia produces steam, it turns a turbine generator to generate electricity. A second pipe extracts cool deep water from the ocean that condenses the steam back to liquid form. As the ammonia is recycled, the process repeats, creating unlimited clean energy, 24 hours a day, 365 days a yea (The Rankine Cycle). OTEC uses the solar energy from the ocean. No fossil fuels are used.

Seawater Air Conditioning (SWAC) technology generates air conditioning without the use of chemical agents. Acting alone, SWAC can lessen electricity usage by up to 90 percent versus traditional air conditioning systems. When developed in association with OTEC plants, SWAC operates totally without the use of fossil fuels.

Last month, Ocean Thermal Energy announced that it has made major progress on the development of its first OTEC EcoVillage. The Company has progressed toward the development of a SWAC system for the U.S. Military.

Regarding the OTEC EcoVillage, the U.S. Virgin Islands’ Public Service Commission granted Ocean Thermal Energy regulatory approval for an OTEC plant. The Company has identified the specific plots of land for the site. The initial draft of the Master Plan for the whole development has been completed.

The OTEC EcoVillage project comprises, in part, of an OTEC plant that will provide all power and water to approximately 400 residences. Additionally, it comprises a hotel, and shopping center, and models of sustainable agriculture, food production, and other economic developments. OTEC EcoVillage will be the first development in the world offering a net-zero carbon footprint.

Ocean Thermal Energy Corporation (CPWR), closed Friday's trading session at $0.48, down 2.04%, on 56,300 volume with 19 trades. The average volume for the last 60 days is 48,096 and the stock's 52-week low/high is $0.0801/$12.25.

graphic

The QualityStocks
Company Corner

graphic
graphic

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF). Today, Global Hemp Group, Inc. closed trading at $0.1217, off by 26.24%, on 451,278 volume with 108 trades. The stock’s average daily volume over the past 60 days is 465,125, and its 52-week low/high is $0.0115/$0.316.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant.

Global Hemp Group, Inc. (GBHPF) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Hemp Group, Inc. Company Blog

Global Hemp Group, Inc. News:

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) and Global Hemp Group Announce Results from First Phase of Industrial Hemp Project

Marijuana Company of America and Global Hemp Group Issue Final Report on New Brunswick Hemp/CBD Project

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0325, up 1.25%, on 18,359,225 volume with 443 trades. The stock’s average daily volume over the past 60 days is 15,119,809, and its 52-week low/high is $0.009/$0.16.

CannabisNewsAudio announces the Audio Press Release (APR) titled "Fired-Up Cannabis Players Ride into 2018 on Year-End High," featuring Global Payout, Inc. (GOHE). To hear the CannabisNewsAudio version, visit http://cnw.fm/I11pi. To read the original editorial, visit http://cnw.fm/B9IYp.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

CannabisNewsAudio Announces Audio Press Release (APR) on Profit Potential Amid Cannabis and Blockchain Market Frenzy

CannabisNewsWire Announces Publication on Innovators Taking Advantage of Cannabis and Blockchain Buzz

MoneyTrac Technology, Inc. in Discussions with POS Company Providing End-to-End Disruptive Application Technology to Complete Suite of Financial Services

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0032, up 3.23%, on 8,942,993 volume with 76 trades. The stock’s average daily volume over the past 60 days is 10,711,328 and its 52-week low/high is $0.0027/$0.1499.

Last October, Grey Cloak Tech (OTCQB: GRCK) entered the CBD market sector through its acquisition of Eqova Life Sciences, an established producer of a wide range of clinical-grade hemp CBD oil products supplying medical practitioners. An article discussing the company reads: “Eqova’s products are not developed for recreational use, and the company only uses natural, standardized phytocannabinoid-rich hemp oil in its medical-grade, CBD-based products.” To view the full article, visit: http://cnw.fm/dQVs5

Grey Cloak Tech, Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, aims to expand into the rapidly growing cannabinoid (CBD) market through the pending acquisition of Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences, based in Denver, Colorado, develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company's CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company's formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The purchase of Eqova Life Sciences would be a natural fit for the company, which has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company's proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases. Disclaimer

Grey Cloak Tech, Inc. Blog

Grey Cloak Tech, Inc. News:

CannabisNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Eqova Life Sciences Provides Quality CBD Products

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Offers Up-to-date Cannabis Information through CBD.co Marketplace

Grey Cloak Tech’s (GRCK) Recent Eqova Acquisition Positions the Company for Growth on Booming CBD Market

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.69, off by 5.48%, on 147,978 volume with 121 trades. The stock’s average daily volume over the past 60 days is 248,611 and its 52-week low/high is $0.40/$2.00.

Market analysis company ChineseInvestors.com (OTCQB: CIIX) has its sights set on making 2018 another successful year through remaining focused on key initiatives. An article discussing the company’s plans reads: “ChineseInvestors.com, Inc.’s (OTCQB: CIIX) mission is to become the leading publicly traded company targeting Chinese medicinal marijuana. To view the full article, visit: http://cnw.fm/HNSz8

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Aims to Double Revenue, Expand in 2018

NetworkNewsAudio Announces Audio Press Release (APR) on Rise and Resilience of Cryptocurrencies

NetworkNewsWire Announces Publication on Emerging Leaders in Blockchain and Cryptos

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.8089, off by 8.80%, on 350,838 volume with 257 trades. The stock’s average daily volume over the past 60 days is 279,742, and its 52-week low/high is $0.3148/$1.3041.

Canadian Silver Hunter Inc. (TSXV: AGH.H) releases positive drill results from the 2017 drill program, conducted by option partner First Cobalt Corp. (FTSSF) intersecting 25 metres of fracture-controlled silver mineralization on Silver Hunter's Keeley-Frontier property. For a table of drill hole assay results to date, visit https://firstcobalt.com/projects/greater-cobalt-project.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

Canadian Silver Hunter Inc. Reports 25 Metres of Mineralization Intersected at Keeley Mine

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Announces Positive Results from 2017 Drill Program

Trent Mell, President and CEO of First Cobalt Corporation Returns to “Stock Day” with Everett Jolly for an Operational Update and 2018 Forecast

Petrogress, Inc. (PGAS)

The QualityStocks Daily Newsletter would like to spotlight Petrogress, Inc. (PGAS). Today, Petrogress, Inc. closed trading at $0.0241, off by 9.06%, on 240,635 volume with 11 trades. The stock’s average daily volume over the past 60 days is 412,578, and its 52-week low/high is $0.017/$0.072.

Marine transport and offshore services company Petrogress (OTC: PGAS) has employed a winning vertical integration strategy in the oil and gas industry, and aims to engage in leasing liquefied natural gas (“LNG”) tankers in the future. An article discussing the company reads: “At some point, Petrogress plans to begin leasing LNG tankers to enter this lucrative market.” To view the full article, visit: http://nnw.fm/9WTzt

Petrogress, Inc. (PGAS) founded in 2009, owns and operates a fleet of tankers from its base in the historic Port of Piraeus, Greece, through a series of Marshall Islands subsidiaries. The company is an international merchant of petroleum products which includes reliably marketing and trading crude oil, distillates, and refined products off the coast of West Africa. The company also operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana. It is actively seeking expansion opportunities, including in operating and developing natural gas production and transmission facilities along with LNG processing in the U.S., refinery operations in north and west Africa, and the transport and sales of LNG in Europe.

Petrogress has created a diversified revenue stream, giving it a significant advantage over similar companies working in the oil and gas shipping arena. A case in point is the recent formation of "PG Cypyard & Offshore Service Terminal Ltd. ("Cypyard"), through the company's wholly owned subsidiary, Petrogress Int'l, LLC. Cypyard is concluding negotiations for an operations and management agreement covering ports in Hellenic Cyprus, including the Port of Limassol, directly with the Cyprus Ports Authority. Current plans include a long-term lease with renewal options covering all in-place port facilities, including floating dock and dry dock areas, with cranes and scaffolding, construction and repair workshops and storage, and complete on-site administrative and office space.

"I think the opportunities there are great, and dealing directly with partners in government has numerous benefits," said Christos P. Traios, president of Petrogress Inc. in a news release announcing the venture. The recent appointment of two industry experts to the Petrogress Advisory Board is expected to help the company capitalize on future growth opportunities while simultaneously developing a comprehensive U.S. and international lobbying and government outreach program to facilitate business plans in the U.S., European Union and Africa.

Additional Petrogress Inc. subsidiaries are:

  • Petrogress Co. Ltd., an international merchant of petroleum products that combines regional market knowledge with over 20 years of excellent shipping experience.
  • Petrogress Co. Ltd., an international merchant of petroleum products that combines regional market knowledge with over 20 years of excellent shipping experience.
  • Petrogress Oil & Gas Energy Inc., which has expansion plans through a supply of liquified natural gas located in the oil fields of Texas with an eye toward exporting LNG to Mediterranean markets.

Petrogress continues to "adjust its sails" in order to meet new challenges. Opportunities include upstream oil resources and exploration, the addition of more product fleet carriers, downstream movement of petroleum products from refineries to finished sales, and sea transportation of liquified natural gas. A closely followed economist, Jim O'Neill, states that oil prices could spike more than 25% in the next year. O'Neill, now an economics professor at the University of Manchester, says the market is finally waking up to the fact that global economic growth is gaining momentum and likely expanding at 4 percent or higher. That means there will be more demand for oil, the article states, which translates into brighter days ahead for companies like Petrogress. Disclaimer

Petrogress, Inc. Company Blog

Petrogress, Inc. News:

NetworkNewsBreaks – Petrogress, Inc. (PGAS) Continues to Advance in the Oil and Gas Industry

NetworkNewsBreaks – Petrogress, Inc. (PGAS) Effective Leadership Maintains Viability through Industry Highs and Lows

NetworkNewsBreaks – Petrogress, Inc. (PGAS) Highlights Three Areas of Focus to Increase Growth in 2018

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0561, off by 9.52%, on 7,842,730 volume with 666 trades. The stock’s average daily volume over the past 60 days is 13,861,128, and its 52-week low/high is $0.0132/$0.415.

Specialized holding company SinglePoint’s (OTC: SING) bitcoin payments solution, set to launch in the first quarter of 2018, will permit underbanked cannabis merchants to accept bitcoin-backed card transactions. An article discussing the company reads: “In any state where cannabis enjoys legal status, the SingleSeed payments platform can be used.” To view the full article, visit: http://nnw.fm/wDYO8. Also today, Singlepoint was featured on MoneyTV with Donald Baillargeon, which can be viewed online at www.moneytv.net.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) SingleSeed Payment Platform to Solve Cannabis Industry Banking Issues

SinglePoint Featured on MoneyTV with Donald Baillargeon, 2/2

NetworkNewsAudio Announces Audio Press Release (APR) on Blockchain's Capability to Create Efficiencies Across Digital Transactions

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.35, off by 21.51%, on 715,927 volume with 1,109 trades. The stock’s average daily volume over the past 60 days is 503,057 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced today that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://cnw.fm/Hef3A).

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement with Cannabis-Infused Edibles Manufacturer

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Offers Potentially Safer Method of Delivering Drug Therapies

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.25, off by 35.06%, on 28,430 volume with 14 trades. The stock’s average daily volume over the past 60 days is 6,330, and its 52-week low/high is $0.01/$0.80.

NetworkNewsWire, a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc. (OTCQB:PRVCF) (CSE:PREV) (FSE:18H), a client of NNW and health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. To view the full publication, titled “Promising New Approaches in Pain Management,” visit: LINK

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsWire Announces Publication on Innovative Approaches in Non-Addictive Analgesics

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

PreveCeutical Signs Research and Option Agreement with UniQuest Pty Limited for Development of Non-Addictive Analgesic Peptides

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(ILUS) +44.00%

2.

CannabisNewsWire
(POTN) +26.43%

3.

NetworkNewsWire
(AVOP) +24.63%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251